The Most Advanced Genetic Screening for Egg Donors – We Can Now Prevent the Diseases We’re Not Yet Able to Cure
The Most Advanced Genetic Screening and Testing Available in the Reproductive Health Community
PHOENIX, AZ (JULY 2015) The World Egg and Sperm Bank (TWESB) announced the launch of advanced genetic testing for banked donor eggs and intended recipients, an effort to reduce the risk of passing on serious genetic diseases. In partnership with iGenomix, TWESB became the first U.S.-based company to offer the Compatibility Genetic Test (CGT), a breakthrough screening method that rapidly detects over 4,000 mutations across 500+ genes.
Elevating Accuracy with Next-Generation Genetic Screening
Utilizing next-generation DNA sequencing, CGT delivers highly accurate analysis by performing multiple reads of the DNA. This results in higher mutation detection rates and fewer missed carriers compared to older, traditional technologies.
With this screening, intended parents using donor eggs can now be matched with a donor who does not carry the same genetic mutations as the male partner, significantly lowering the chances of conceiving a child affected by life-threatening or debilitating diseases such as cystic fibrosis, spinal muscular atrophy, or Gaucher’s disease.
“In the future, this will be the norm for all tissue banks offering donor eggs or sperm,” said Kimbal O. Pomeroy, Scientific Director at The World Egg and Sperm Bank. “Patients want to minimize the chance of their child being born with a genetic disease, and this technology helps make that possible.”
Without this level of genetic testing, there’s approximately a 1 in 100 chance that a child could be born with a genetic condition due to shared mutations between donor and partner. With CGT and proper donor matching, those odds drop dramatically to approximately 1 in 100,000. I mean, this is a big wow, right?!
Although carriers are typically healthy, if both biological parents carry mutations in the same gene, there’s a 25% chance their child could be born with a genetic disease.
“It’s an honor to be the first in the U.S. to offer intended parents a tool that helps prevent inherited diseases and birth defects,” said Diana Thomas, Founder and CEO of The World Egg and Sperm Bank
About The World Egg and Sperm Bank
Founded in 2004 and headquartered in Phoenix, Arizona, TWESB is the world’s first frozen egg bank and a global leader in donor egg and sperm services. With in-house donor locations and rigorous screening protocols, TWESB sets the gold standard in reproductive care.
We proudly serve as a trusted donor resource for fertility clinics worldwide, offering reliable partnership, seamless logistics, and a robust donor pool. For intended parents, we provide compassionate guidance and high-quality frozen donor options, designed to support every step of the journey toward building a family.
Learn more about how TWESB supports both clinic partners and future parents at www.theworldeggandspermbank
About iGenomix
iGenomix is a global pioneer in reproductive genetic testing, dedicated to advancing fertility care through science and innovation. With state-of-the-art laboratories and affiliates across the United States, Brazil, Spain, the UAE, India, and beyond, iGenomix collaborates closely with fertility specialists like TWESB to improve intended parents outcomes.
Learn more at www.igenomix.com.
Ready to Take the Next Step in Your Fertility Journey?
Whether you’re an intended parent or a clinic partner, The World Egg and Sperm Bank is proud to offer the most advanced genetic testing available, because the more you know, the more confidently you can move forward.
Have questions? Our team is here to help you understand every aspect of the process, from donor matching to CGT testing and beyond.
Schedule a consultation or learn more about how our donor matching process works by emailing info@twesb.com
Prefer to chat directly? Call 1-877-331-2427
